We also performed Western blot analyses to detect the levels of CDYL, EZH2, and CDKN1C in xenograft tumours, and GSK126 significantly increased CDKN1C levels in CDYL-overexpressing H69 cells, but did not significantly change CDYL levels (Figure 6E). The gene discussed is CDKN1C; the disease is neoplasm.